CVS Health Corp ( (CVS) ) has released its Q4 earnings. Here is a breakdown of the information CVS Health Corp presented to its investors.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
CVS Health Corporation is a prominent player in the health solutions sector, operating across retail pharmacy, health insurance, and pharmacy benefit management, with a unique integrated model aimed at enhancing consumer health outcomes. CVS Health Corp reported a 4.2% increase in total revenues for both the fourth quarter and full year of 2024, reaching $97.7 billion and $372.8 billion, respectively, despite reduced operating income and EPS compared to the previous year. The company’s earnings were affected by continued pressures in its Health Care Benefits segment, though growth was noted in the Pharmacy and Consumer Wellness segment. The Health Care Benefits segment faced challenges with increased utilization and unfavorable Medicare Advantage star ratings, resulting in significant declines in operating income. Conversely, the Pharmacy & Consumer Wellness segment experienced revenue growth due to increased prescription volumes, although facing reimbursement pressures. Looking ahead, CVS Health provides guidance for 2025 with expectations of increased EPS and cash flow from operations, indicating confidence in overcoming current segment challenges and continuing growth, particularly in the Pharmacy and Consumer Wellness sector.
